Thermo Fisher Scientific (NYSE: TMO) reported Q3 EPS of $5.69, $0.06 better than the analyst estimate of $5.63. Revenue for the quarter came in at $10.57 billion versus the consensus estimate of $10.62 billion.

GUIDANCE:

Thermo Fisher Scientific sees FY2023 EPS of $21.50, versus the consensus of $22.31. Thermo Fisher Scientific sees FY2023 revenue of $42.7 billion, versus the consensus of $43.53 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.